Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -47.95% is 34% above its 5-year average of -72.13%, near the high end of its 5-year range (-149.14%–-16.62%).
21.71% below its 12-month average of -39.40%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -16.62%.
OPERATING MARGIN
-47.95%
OPERATING MARGIN AVG TTM
-39.40%
OPERATING MARGIN AVG 3Y
-63.06%
OPERATING MARGIN AVG 5Y
-72.13%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-21.71%
CURRENT VS 3Y AVG
+23.96%
CURRENT VS 5Y AVG
+33.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sight Sciences, Inc.
Market Cap
$465.75M
Operating Margin
-47.95%
TTM Avg
-39.40%
3Y Avg
-63.06%
5Y Avg
-72.13%
Market Cap
$469.12M
Operating Margin
-36.19%
TTM Avg
-55.58%
3Y Avg
-82.00%
5Y Avg
-57.61%
Market Cap
$471.57M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$471.65M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
Market Cap
$472.23M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$475.91M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-8.04%
5Y Avg
-6.43%
Market Cap
$483.54M
Operating Margin
13.16%
TTM Avg
14.88%
3Y Avg
13.50%
5Y Avg
6.84%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $465.75M | -47.95% | -39.40% | -63.06% | -72.13% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 14.51% | 13.50% | 9.39% | 8.55% |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -36.19% | -55.58% | -82.00% | -57.61% |
| Cerus Corporation (CERS)vs › | $471.57M | -0.73% | -6.05% | -13.09% | -25.54% |
| Arvinas, Inc. (ARVN)vs › | $471.65M | -43.75% | -69.37% | -212.63% | -278.07% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 0.00% | 0.00% | -8.04% | -6.43% |
| NRC Health (NRC)vs › | $452.54M | 10.53% | 20.52% | 24.67% | 27.45% |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 13.16% | 14.88% | 13.50% | 6.84% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.00% | -95.56% | -362.67% | -2402.18% |
Gross Margin
88.0%
Operating Margin
-48.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -16.62% |
| 2026-03-31 | -63.02% |
| 2025-12-31 | -18.00% |
| 2025-09-30 | -39.71% |
| 2025-06-30 | -59.64% |
| 2025-03-31 | -79.16% |
| 2024-12-31 | -62.54% |
| 2024-09-30 | -55.71% |
| 2024-06-30 | -59.20% |
| 2024-03-31 | -76.42% |
| 2023-12-31 | -59.25% |
| 2023-09-30 | -67.02% |
| 2023-06-30 | -64.71% |
| 2023-03-31 | -93.33% |
| 2022-12-31 | -83.01% |
| 2022-09-30 | -116.96% |
| 2022-06-30 | -132.71% |
| 2022-03-31 | -149.14% |
| 2021-12-31 | -100.21% |
| 2021-09-30 | -107.09% |
| 2021-06-30 | -88.36% |
| 2021-03-31 | -134.99% |
| 2020-12-31 | -93.79% |
| 2020-09-30 | -85.02% |
| 2020-06-30 | -219.59% |
| 2020-03-31 | -134.08% |
